Online Engagement Rules & Advice For Physicians
Social media and the internet in general is an invaluable tool for healthcare professionals and physicians, however it doesn’t come without its cautions and its challenges. According to a position paper from the American College of Physicians and the Federation of State Medical Boards published in Annals of Internal Medicine the internet represents “a new frontier in medicine” but it also “present numerous and novel challenges to professionalism.”
The paper outlined a new conceptual “framework for analysing medical ethics and professionalism issues” on the internet and provides recommendations for physicians on the use of email, blog, social media sites and more.
Read Related Articles On Healthcare Global
- Businessfriend Gives Social Media A Boost In Healthcare
- Top Social Networks For Healthcare Professionals
- Tips For Developing A Hospital mHealth Strategy
Healthcare Global highlights some of the paper’s suggestions for online communication for safe and effective online engagement >>>
#1. When communicating with patients, physicians should “consistently apply ethical principles for preserving the relationship, confidentiality, privacy, and respect for persons to online settings and communications.”
#2. Pause before posting. The paper states that “the ease of use and immediacy of social media tools can lead to unintended outcomes or messages.”
#3. Avoid patient targeted Googling. Although there are numerous valuable educational resources available, the paper advises physicians to evaluate the quality of online content before giving recommendations to their patients.
#4. Never use the internet to complain about patients, name or no name. Physicians who use blogs, Twitter and other outlets to vent against patients are “disrespectful” and may “undermine trust in the profession.”
#5. Maintain clear and distinct professional and social identities online, but professional standards must be maintained in both spheres. Patients should not be “friended” by physicians and should not be included in the personal or social online interactions of physicians.
#6. Avoid medical humor. Medical humor, though intended for fellow professionals, can easily find a wider audience on the internet.
Introducing Dosis - the AI powered dosing platform
Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works.
When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing.
The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced.
What is the Strategic Anemia Advisor?
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease.
SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool.
What else is Dosis working on?
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs.
What are Dosis' strategic goals for the next 2-3 years?
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.
What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.